Acute blood loss produces a constellation of physiological responses that aid in the restoration of cardiovascular homeostasis. These compensatory responses include increased constriction of blood vessel and cardiac output brought about, in part, by a stimulation of the sympathetic nervous. However, beyond a critical level of blood loss a seemingly paradoxical reversal of the automatic compensations occurs, leading to a dramatic decrease in arterial pressure. This decompensatory phase of the hemorrhage response is associated with an inhibition of some sympathetic nerves and a decrease in peripheral vascular resistance. Hemorrhage-induced sympathoinhibition is triggered by the activation of cardiac vagal afferents that project to the nucleus tractus solitarius (NTS), but the central mechanism underlying this response remains unknown. Hemorrhage- induced sympahtoinhibition may be produced by a inhibition of neurons in the rostral ventrolateral medulla (RVLM) that provide the major source of tonic excitatory drive to sympathetic vasoconstrictor nerves. Several reflexes that are also triggered by afferents to NTS inhibit sympathetic vasomotor tone (e.g. baroreceptor reflex and Bexold-Jarish reflex)by inhibiting RVLM presympathetic neurons via the excitation of a GABAerigic projection from the caudal ventrolateral medulla (CVLM). However, in contrast to these other reflexes, centrally-acting opiates appears to be crucial for hemorrage-induced sympathoinhibition.. Opiate receptor blockade centrally but not peripherally can reverse hemorrhage-induced sympathoinhibition, but the central mechanism underlying the opiate contribution to this response is not known. Because opiates can inhibit RVLM presympathetic neurons directly, hemorrhage-induced sympathoinhibition may occur by a release of opiates into RVLM that is independent of an inhibilitory projection from V|CVLM. This application has two goals: 1) to reveal the central circuitry for hemorrhage-induced symphathoinhibition, and 2) to determine the role of opiate peptides in this process.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32HL009643-02
Application #
2637933
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1998-01-01
Project End
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Virginia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Schreihofer, A M; Stornetta, R L; Guyenet, P G (1999) Evidence for glycinergic respiratory neurons: Botzinger neurons express mRNA for glycinergic transporter 2. J Comp Neurol 407:583-97